Ulf Grawunder
22Patents
4h-index
15Co-inventors
60Inventor score
Filing activity: Dec 22, 2001 → Jul 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7741077B2 | Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins | Chemistry; Metallurgy | 23 | Expired |
| US9872923B2 | Method of producing an immunoligand/payload conjugate | Chemistry; Metallurgy | 14 | Active |
| US10864277B2 | Method of producing an immunoligand/payload conjugate | Chemistry; Metallurgy | 8 | Active |
| US11242388B2 | ROR1 antibody compositions and related methods | Chemistry; Metallurgy | 6 | Active |
| US11364301B2 | Method of producing an immunoligand/payload conjugate | Chemistry; Metallurgy | 3 | Active |
| US10618959B2 | ROR1 antibody compositions and related methods | Chemistry; Metallurgy | 3 | Active |
| US10174309B2 | Transposition-mediated identification of specific binding or functional proteins | Chemistry; Metallurgy | 2 | Active |
| US10188745B2 | Binding protein drug conjugates comprising anthracycline derivatives | Chemistry; Metallurgy | 2 | Active |
| US10960083B2 | Binding protein drug conjugates comprising anthracycline derivatives | Chemistry; Metallurgy | 2 | Active |
| US10517959B2 | Binding protein drug conjugates comprising anthracycline derivatives | Chemistry; Metallurgy | 2 | Active |
| US11447546B2 | Human antibodies binding to ROR2 | Chemistry; Metallurgy | 1 | Active |
| US9346874B2 | Binding members for human cytomegalovirus | Chemistry; Metallurgy | 1 | Active |
| US10758556B2 | Anthracycline-based antibody drug conjugates having high in vivo tolerability | Chemistry; Metallurgy | 1 | Active |
| US8748353B2 | Identification of antigen or ligand-specific binding proteins | Chemistry; Metallurgy | 1 | Active |
| US8716194B2 | Identification of antigen or ligand-specific binding proteins | Chemistry; Metallurgy | 1 | Active |
| US9593327B2 | Identification of antigen or ligand-specific binding proteins | Chemistry; Metallurgy | 1 | Active |
| US12275789B2 | Human antibodies binding to ROR2 | Chemistry; Metallurgy | 0 | Active |
| US11845793B2 | Anti-ROR1 antibodies | Chemistry; Metallurgy | 0 | Active |
| US11833120B2 | Binding protein drug conjugates comprising anthracycline derivatives | Chemistry; Metallurgy | 0 | Active |
| US11986535B2 | Method of producing an immunoligand/payload conjugate | Chemistry; Metallurgy | 0 | Active |
| US12121527B2 | Anthracycline-based antibody drug conjugates having high in vivo tolerability | Chemistry; Metallurgy | 0 | Active |
| US10502745B2 | Identification of antigen- or ligand-specific binding proteins | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.